A sensitive method to detect synthesis of the functional classical, alternative and terminal pathway of complement by cells cultured in vitro

References

• Stecher VJ, Morse JH, Thorbecke GJ. Sites of production of primate serum proteins associated with the complement system. Proc Soc Exp Biol 1967; 124: 433–8
   Google Scholar
• Einstein PL, Schneeberger EE, Colten HR. Synthesis of the second component of complement by long-term primary cultures of human monocytes. J Exp Med 1976; 143: 114–26
   Google Scholar
• Ackerman SK, Friend PS, Høidal JR, Douglas SD. Production of C2 by human alveolar macrophages. Immunology 1978; 35: 369–72
   PubMed Web of Science ®Google Scholar
• Loos M, Müller W, Storz R. In vitro synthesis of the first component of complement (CI) by human and guinea-pig peritoneal macrophages. J Immunol 1978; 120: 1783–93
   Google Scholar
• Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative pathway by human peripheral blood monocytes. J Exp Med 1980; 151: 501–16
   PubMed Web of Science ®Google Scholar
• Bentley C, Zimmer B, Hadding V. The macrophage as a source of complement components. Lymphokines 1981; 4: 197–230
   Google Scholar
• Brade V, Kreuzpainter G. Functional active complement components secreted by guinea-pig peritoneal macrophages. Immunobiol 1982; 161: 315–27
   Google Scholar
• Cole SF, Matthews WR, Jr., Rossing TH, Gash DJ, Lichtenberg NA, Pennington JE. Complement biosynthesis by human bronchoalveolar macrophages. Clin Immunol Immunopathol 1983; 27: 153–9
   PubMedGoogle Scholar
• Laiwah ACY, Jones L, Hamilton AOS, Whaley K. Complement-subcomponent-CI-inhibitor synthesis by human monocytes. Biochem J 1985; 226: 199–205
   Google Scholar
• Hetland G, Johnson E, Falk RJ, Esekland T. Synthesis of complement components C5, C6. C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex. Scand J Immunol 1986; 24: 421–8
   Google Scholar
• Hetland G, Johnson E, Aasebø U. Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro. Scand J Immunol 1986; 24: 603–8
   Google Scholar
• Pettersen HB, Johnson E, Hetland G. Human alveolar macrophages synthesize in vitro active complement components C6, C7 and C8. Scand J Immunol 1987; 25: 567–70
   Google Scholar
• Hetland G, Johnson E, Røyset P, Eskeland T. Human alveolar macrophages and monocytes generate the functional classical pathway of complement in vitro. Acta Path Scand Section C 1987; 95: 117–22
   Google Scholar
• Hetland G, Johnson E, Eskeland T. Formation of the membrane attack complex of complement (MAC) on erythrocytes from monocyte-produced terminal complement components. Scand J Immunol 1987; 25: 571–7
   Google Scholar
• Gee JBL. Bronchoalveolar lavage. Thorax 1980; 35: 1–8
   Google Scholar
• Lachmann PJ, Oldroyd RG, Milstein C, Wright BW. Three rat monoclonal antibodies to C3. Immunology 1980; 41: 503–15
   Google Scholar
• Lachmann PJ, Pangburn MK, Oldroyd RG. Breakdown of C3 after complement activation. Identification of a new fragment. C3g, using monoclonal antibodies. J Exp Med 1982; 156: 205–16
   PubMed Web of Science ®Google Scholar
• Hammer CH, Wirtz GH, Renfer L, Gresham HD, Tack BF. Large scale isolation of functionally active components of the human complement system. J Biol Chem 1981; 256: 3995–4003
   PubMed Web of Science ®Google Scholar
• Podack ER, Müller-Eberhard HJ. Isolation of human S-protein an inhibitor of the membrane attack complex of complement. Biol Chem 1979; 254: 9908–14
   Google Scholar
• Lachmann PJ, Hobart MJ. Chapter 5A. Handbook of Experimental Immunology 3rd edn., DM Weir. Blackwell Scientific Publications Ltd, Oxford 1978; 5A9
   Google Scholar
• Mollnes TE, Lea T, Harboe M, Tschopp J. Monoclonal antibodies recognizing a neoantigen of poly (C9) detect the human terminal complement in tissue and plasma. Scand J Immunol 1985; 22: 183–95
   PubMed Web of Science ®Google Scholar
• Falk RJ, Augustin PD, Younghi K, Cheng HT, Scheimann JI, Gewurz H, Michael A. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest 1983; 72: 560–73
   PubMed Web of Science ®Google Scholar
• Salacinski PRP, McLean C, Sykes JEC, Clement-Jones VV, Lowry PJ. Iodinations of proteins, glycoproteins, and peptides using a solid phase oxidizing agent (Iodogen). Anal Biochem 1981; 117: 136–46
   PubMed Web of Science ®Google Scholar
• Pepys MB, Bell AJ, Rowe IF. I. Preparation and use as an immunosorbent. Scand J Immunol 1976, Suppl 3: 74–8
   Google Scholar
• Johnson E, Eskeland T. Complement (C3)-receptor-mediated phagocystosis of agarose beads by mouse macrophages. I. Intracellular degradation of agarose-bound C3bi and C3b by lysosomal enzymes. Scand J Immunol 1983; 18: 193–9
   Google Scholar
• Müller-Eberhard HJ, Schreiber RD. Molecular biology and chemistry of the alternative pathway of complement. Adv Immunol 1980; 29: 1–53
   PubMedGoogle Scholar
• Vogt W, Schmidt G, Von Buttlar B, Dieminger L. A new function of the activated third component of complement: binding to C5, an essential step for C5 activation. Immunology 1978; 34: 29–40
   PubMed Web of Science ®Google Scholar
• Gronski P, Bodenbender L, Kanzy E-J, Piepen-Brock M, Seiler FR. The functional inhibition of Clinhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4 and factor B. Immunobiol 1986; 171: 252–62
   Google Scholar
• St John Sutton MB, Strunk RC, Cole FS. Regulation of the synthesis of the third component of complement and factor B in cord blood monocytes by lipopolysaccharide. J Immunol 1986; 136: 1366–72
   Google Scholar
• Seljelid R, Bøgwald J, Lundwall Å. Glycan stimulation of macrophages in vitro. Exp Cell Res 1981; 131: 121–30
   PubMed Web of Science ®Google Scholar